Sub-Saharan Africa’s already slow vaccination campaigns received another blow with news this week that a key supplier, India’s Serum Institute, is delaying shipments further. African policymakers will probably struggle to fill the vaccine supply gap and, as a result, containment measures will have to stay in place for longer and fresh virus waves will remain a key risk. Economic activity will stay subdued and the region is likely to be one of the last to emerge from the coronavirus crisis.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services